Pancreatic NeuroEndocrine Tumors (PanNET) research hub

First adjuvant trial in locally resected aggressive pancreatic neuroendocrine tumors: a randomized phase III investigating the efficacy of systemic chemotherapy (ADJUPANET)

This study is looking at whether chemotherapy after surgery for a type of pancreatic cancer helps stop it from coming back. It compares a chemotherapy drug combination to just standard observation to see which approach leads to longer periods without the cancer returning.